Noam Driguès

580 total citations
9 papers, 495 citations indexed

About

Noam Driguès is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Noam Driguès has authored 9 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Neurology. Recurrent topics in Noam Driguès's work include Parkinson's Disease Mechanisms and Treatments (3 papers), Biochemical effects in animals (2 papers) and Nuclear Receptors and Signaling (2 papers). Noam Driguès is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (3 papers), Biochemical effects in animals (2 papers) and Nuclear Receptors and Signaling (2 papers). Noam Driguès collaborates with scholars based in Israel and United States. Noam Driguès's co-authors include Abraham Z. Reznick, Ifat Klein, Rafael M. Nagler, Moussa B. H. Youdim, Yotam Sagi, Tamar Amit, Orly Weinreb, Eric Diamond, Sophie Lischinsky and Tatyana Poltyrev and has published in prestigious journals such as Free Radical Biology and Medicine, British Journal of Pharmacology and Archives of Biochemistry and Biophysics.

In The Last Decade

Noam Driguès

9 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Noam Driguès Israel 8 242 119 97 70 60 9 495
Kiyoshi Terawaki Japan 17 164 0.7× 186 1.6× 25 0.3× 35 0.5× 52 0.9× 36 737
Katherine Forman Spain 13 170 0.7× 137 1.2× 31 0.3× 21 0.3× 33 0.6× 19 529
Jonathan Fusi Italy 15 180 0.7× 111 0.9× 12 0.1× 53 0.8× 30 0.5× 28 498
Ana Paula Oliveira Ferreira Brazil 12 64 0.3× 127 1.1× 18 0.2× 46 0.7× 41 0.7× 12 420
Paulo Fernando Santos Mendes Brazil 7 148 0.6× 106 0.9× 23 0.2× 28 0.4× 48 0.8× 18 393
Chih‐Yuan Ko China 13 199 0.8× 221 1.9× 12 0.1× 50 0.7× 31 0.5× 38 506
Tae Ju Park South Korea 14 158 0.7× 195 1.6× 8 0.1× 70 1.0× 74 1.2× 29 592
Azam Bakhtiarian Iran 14 102 0.4× 161 1.4× 7 0.1× 124 1.8× 59 1.0× 66 564
Antonina Gucciardi Italy 16 146 0.6× 124 1.0× 9 0.1× 17 0.2× 17 0.3× 30 503
Mina Gholami Iran 13 77 0.3× 138 1.2× 7 0.1× 92 1.3× 60 1.0× 36 513

Countries citing papers authored by Noam Driguès

Since Specialization
Citations

This map shows the geographic impact of Noam Driguès's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noam Driguès with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noam Driguès more than expected).

Fields of papers citing papers by Noam Driguès

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noam Driguès. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noam Driguès. The network helps show where Noam Driguès may publish in the future.

Co-authorship network of co-authors of Noam Driguès

This figure shows the co-authorship network connecting the top 25 collaborators of Noam Driguès. A scholar is included among the top collaborators of Noam Driguès based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noam Driguès. Noam Driguès is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Weinreb, Orly, Tamar Amit, Yotam Sagi, Noam Driguès, & Moussa B. H. Youdim. (2009). Genomic and proteomic study to survey the mechanism of action of the anti-Parkinson’s disease drug, rasagiline compared with selegiline, in the rat midbrain. Journal of Neural Transmission. 116(11). 1457–1472. 25 indexed citations
2.
Weinreb, Orly, Orit Bar‐Am, Tamar Amit, et al.. (2008). The neuroprotective effect of ladostigil against hydrogen peroxide-mediated cytotoxicity. Chemico-Biological Interactions. 175(1-3). 318–326. 34 indexed citations
3.
Weinreb, Orly, Noam Driguès, Yotam Sagi, et al.. (2006). The Application of Proteomics and Genomics to the Study of Age-Related Neurodegeneration and Neuroprotection. Antioxidants and Redox Signaling. 0(0). 3669589924–3669589924. 2 indexed citations
4.
Weinreb, Orly, Noam Driguès, Yotam Sagi, et al.. (2006). The Application of Proteomics and Genomics to the Study of Age-Related Neurodegeneration and Neuroprotection. Antioxidants and Redox Signaling. 9(2). 169–179. 38 indexed citations
5.
Sagi, Yotam, Noam Driguès, & Moussa B. H. Youdim. (2005). The neurochemical and behavioral effects of the novel cholinesterase–monoamine oxidase inhibitor, ladostigil, in response to L‐dopa and L‐tryptophan, in rats. British Journal of Pharmacology. 146(4). 553–560. 18 indexed citations
6.
Driguès, Noam, Tatyana Poltyrev, Corina Bejar, Marta Weinstock, & M.B.H. Youdim. (2003). cDNA gene expression profile of rat hippocampus after chronic treatment with antidepressant drugs. Journal of Neural Transmission. 110(12). 1413–1436. 47 indexed citations
7.
Youdim, Moussa B. H., Noam Driguès, & Silvia Mandel. (2003). Oxidative Stress Indices in Parkinson's Disease: Biochemical Determination. Humana Press eBooks. 62. 137–153. 11 indexed citations
8.
Nagler, Rafael M., et al.. (2002). Characterization of the differentiated antioxidant profile of human saliva. Free Radical Biology and Medicine. 32(3). 268–277. 226 indexed citations
9.
Nagler, Rafael M., Sophie Lischinsky, Eric Diamond, et al.. (2000). Effect of Cigarette Smoke on Salivary Proteins and Enzyme Activities. Archives of Biochemistry and Biophysics. 379(2). 229–236. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026